miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
about
The expanding regulatory universe of p53 in gastrointestinal cancerRecent advances in the molecular diagnostics of gastric cancerThe functional sites of miRNAs and lncRNAs in gastric carcinogenesisIdentifying cancer-related microRNAs based on gene expression data.MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene.MicroRNAs as potential biomarkers for gastric cancer.The Fibroblast Growth Factor signaling pathwayExpression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cellsMicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expressionMiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.miR-101 inhibits glioma cell invasion via the downregulation of COX-2.The anti-apoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer.miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13.Regulation of microRNAs in cancer metastasis.Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.The role of microRNA-26a in human cancer progression and clinical application.MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis.Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.Prognostic value of microRNAs in gastric cancer: a meta-analysisMicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1.miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1.Förster resonance energy transfer to impart signal-on and -off capabilities in a single microRNA biosensor.Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.[MicroRNA-26a and Tumor].Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer.Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2.miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer.MicroRNA Expression Profiles in Gastric Carcinogenesis
P2860
Q26742058-A77A3F3E-7737-4F47-8ED7-6FCD9CB65358Q26785548-F6C478EA-7824-4A00-838E-55C2360FE5BDQ27026837-9877C736-2D79-4E3A-8A60-5E7FD7797E15Q30878074-4B5C0883-A4BC-4CA0-91F8-100BECB50316Q33886196-C8C27005-97F7-4A03-99FE-22B0FB83B9F4Q34168445-43D61C4B-8EED-4F27-A194-89FBE6B645B0Q34467171-1B62426A-4814-4D0F-BAF0-AA60E30A940DQ35203269-695B9CB3-1031-4D47-A892-3F2E9D429BFBQ35618147-02181707-BDD5-40D1-83BA-3594408E54A2Q35678702-9A697D3E-28AF-41E5-9B49-EA342A8DF5C8Q35968528-F59846A7-9D05-48E9-AB41-88EEC1066731Q36686905-D8DDEFEC-8632-46A4-A747-505025D4B4A0Q36733776-DDF2B9F7-B41B-47EF-962C-F37FDCAB9C19Q36841322-82ED1AF1-155F-455C-89B6-F344ABFBCEB3Q37046835-81227495-E760-472D-8911-B6C5EE1C4B75Q37288437-CFA79AFD-0AAF-4696-B23C-3211C008DCE4Q37392801-3E23AD39-F445-4769-B2A9-EF740122CE1FQ37564535-F26124DA-92EE-44FC-9395-6C3B83F006CEQ38191102-318E5EEA-B96A-46C9-BEEB-3195D3FC4F0AQ38572855-5C251EE0-DF98-4A06-848B-F2B1C43DCD74Q38714023-B20B052C-1EB7-4734-9CC7-BA4AC0EAF42DQ38736898-0D77B8C3-E021-4E8C-A3DC-CA67A1B056E2Q38796729-2284155C-7F01-4819-8565-08555CBF7003Q38828580-14504C41-B144-4C8C-80C5-3C497B2F40C4Q39012739-B7148728-DB43-4534-9113-BE10A60622FEQ39237748-3CF41EEB-0940-43B1-A489-2AA538A9EDF9Q39346497-DB862F8E-7A97-4804-818C-CC37372814DDQ41548169-145D995C-1664-4E6E-8715-C72B7A04F17BQ41856145-2A0720A4-2C24-4D19-AF1E-A66674B44270Q42215399-69386B5A-A438-4193-8DEB-6B27DA1EA174Q46317673-4039BE98-E0DB-4081-B7FD-9D5A142CC12BQ48103728-3011A6C2-954D-4ADA-A72E-5BEB5989C554Q49236880-21A0E6F8-FB04-4305-8654-2BF4E18EDFBBQ49790324-357DFF3C-7672-43A9-BD27-F4AF3650767BQ50147073-16C43B90-D27E-48F4-B8B9-FC7162861998Q54094778-26C8CD38-1D98-4EBD-B2E3-55A8C1A73488Q54146288-0459A3AC-688A-449D-B80A-E2F10AC4164BQ55293830-6522BA5E-34CC-4E3F-B522-CB9BDC710BF8Q55711392-BC2989B2-037D-4D5C-BBCF-77C8F91C43FEQ58695821-7E31F6FD-CD49-4504-83A6-9B9680AB9735
P2860
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@ast
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@en
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@nl
type
label
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@ast
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@en
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@nl
prefLabel
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@ast
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@en
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@nl
P2093
P2860
P1433
P1476
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.
@en
P2093
Hai-lin Tang
Ji-fang Liu
Mei-yuan Liu
Xi-hong Lu
Xiao-min Lu
Zhi-min He
P2860
P304
P356
10.1371/JOURNAL.PONE.0072662
P407
P577
2013-08-28T00:00:00Z